3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
34
Neoplasm Metastasis
5
Breast Neoplasms
4
Prostate Carcinoma Metastatic to the Bone
2
Multiple Myeloma
2
Metastatic Castration-resistant Prostate Cancer
2
Hormone Refractory Prostate Cancer
2
Carcinoma, Renal Cell
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Prostate Cancer Metastatic to Bone
1
Prostate Adenocarcinoma
1
Neoplasms
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Castrate-Resistant Prostate Cancer
1
Bone Metastatic Castration-resistant Prostate Cancer
1
Bone Metastases
1
Bone Diseases
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
pembrolizumab
2
Injections
2
Abiraterone Acetate
2
radium Ra 223 dichloride
1
niraparib
1
enzalutamide
1
efineptakin alfa
1
darolutamide
1
capivasertib
1
cabazitaxel
1
apalutamide
1
abiraterone
1
Solutions
1
Prednisone
1
Lutetium-177
1
Lutetium
1
Docetaxel
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Metastatic Castration-resistant Prostate Cancer (mCRPC)
×
radium Ra 223 dichloride
×
Clear all
NCT03903835
2025-04-09
ProBio
Karolinska Institutet
Phase 3
Recruiting
750 enrolled